Document Detail

Statin use during pregnancy: a systematic review and meta-analysis.
MedLine Citation:
PMID:  22390808     Owner:  NLM     Status:  MEDLINE    
Statins enjoy widespread acceptance as effective drugs to reduce morbidity and mortality in patients with and without cardiovascular disease, and are considered safe for long-term use. However, these compounds are contraindicated during pregnancy based on their potential teratogenic effects. Owing to the increasing number of young women eligible for statin therapy and the concern that the discontinuation of statin therapy might be harmful for both mother and child with hypercholesterolemia, gestational exposure to statins has increasingly become an issue of significant clinical importance. In this systematic review of both human and animal studies on the teratogenic effects of statins during pregnancy, we found that most of the available data in fact suggests that statins are unlikely to be teratogenic. In humans, the observed congenital anomalies were isolated and no consistent pattern has emerged to suggest that a common mechanism could underlie these observations. Animal studies show conflicting results, but in the reports in which an excess of congenital anomalies was reported in the statin-treated rodents, excessive doses were used compared with the regimens we commonly prescribe to human subjects.
D Meeike Kusters; Hajar Hassani Lahsinoui; Joris A M van de Post; Albert Wiegman; Frits A Wijburg; John J P Kastelein; Barbara A Hutten
Related Documents :
8159368 - Intrauterine pregnancy following endometrial ablation.
562068 - Genital malignancy in pregnancy.
974928 - Perforated peptic ulcer in pregnancy with survival of mother and child: case report and...
12077548 - Multiple hpv-positive basal cell carcinomas on the abdomen in a young pregnant woman.
10796118 - Transcutaneous electrostimulation for suspected placental insufficiency (diagnosed by d...
17705108 - First delivery of healthy offspring after freezing and thawing of oocytes in switzerland.
Publication Detail:
Type:  Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Expert review of cardiovascular therapy     Volume:  10     ISSN:  1744-8344     ISO Abbreviation:  Expert Rev Cardiovasc Ther     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-03-06     Completed Date:  2012-08-02     Revised Date:  2014-03-31    
Medline Journal Info:
Nlm Unique ID:  101182328     Medline TA:  Expert Rev Cardiovasc Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  363-78     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abnormalities, Drug-Induced / etiology
Hydroxymethylglutaryl-CoA Reductase Inhibitors / contraindications,  therapeutic use*
Hypercholesterolemia / drug therapy*
Pregnancy Complications*
Pregnancy Outcome
Reg. No./Substance:
0/Hydroxymethylglutaryl-CoA Reductase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  HDL dysfunction in diabetes: causes and possible treatments.
Next Document:  Guidelines for the prevention of cardiovascular disease in women: international challenges and oppor...